EpiAxis
  • Home
  • About Us
    • An introduction
    • Board
    • Management
    • Collaborators
    • Media
  • Pipeline
    • Pipeline
    • Scientific background
  • Our news
  • Contact
Select Page

Papers

2020 –  Targeting Nuclear LSD1 to Reprogram Cancer Cells and Reinvigorate Exhausted T Cells via Novel LSD1-EOMES Switch

2020 – Epitherapy and immune checkpoint blockade: using epigenetic reinvigoration of exhausted and dysfunctional T cells to reimburse immunotherapy response

2019 – Immune modulation via epigenetic targeting to overcome immune checkpoint inhibitor resistance

2019 – Lysine-Specific Histone Demethylase 1A Regulates Macrophage Polarization and Checkpoint Molecules in the Tumor Microenvironment of Triple-Negative Breast Cancer

2018 – LSD1 Activation Promotes Inducible EMT Programs and Modulates the Tumour Microenvironment in Breast Cancer

2016 – Identification of chromatin accessibility domains in human breast cancer stem cells

Copyright © 2019 - EpiAxis Therapeutics | Privacy Policy